Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 433

1.

Assessment of myocardial metabolism in diabetic rats using small-animal PET: a feasibility study.

Welch MJ, Lewis JS, Kim J, Sharp TL, Dence CS, Gropler RJ, Herrero P.

J Nucl Med. 2006 Apr;47(4):689-97.

2.

Cardiac and skeletal muscle fatty acid transport and transporters and triacylglycerol and fatty acid oxidation in lean and Zucker diabetic fatty rats.

Bonen A, Holloway GP, Tandon NN, Han XX, McFarlan J, Glatz JF, Luiken JJ.

Am J Physiol Regul Integr Comp Physiol. 2009 Oct;297(4):R1202-12. doi: 10.1152/ajpregu.90820.2008. Epub 2009 Aug 12.

3.

Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging.

Rijzewijk LJ, van der Meer RW, Lamb HJ, de Jong HW, Lubberink M, Romijn JA, Bax JJ, de Roos A, Twisk JW, Heine RJ, Lammertsma AA, Smit JW, Diamant M.

J Am Coll Cardiol. 2009 Oct 13;54(16):1524-32. doi: 10.1016/j.jacc.2009.04.074.

5.

Defect in glucokinase translocation in Zucker diabetic fatty rats.

Fujimoto Y, Donahue EP, Shiota M.

Am J Physiol Endocrinol Metab. 2004 Sep;287(3):E414-23. Epub 2004 May 11.

6.

Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid.

Turpeinen AK, Takala TO, Nuutila P, Axelin T, Luotolahti M, Haaparanta M, Bergman J, Hämäläinen H, Iida H, Mäki M, Uusitupa MI, Knuuti J.

Diabetes. 1999 Jun;48(6):1245-50.

PMID:
10342811
7.

Lipid-induced beta-cell dysfunction in vivo in models of progressive beta-cell failure.

Goh TT, Mason TM, Gupta N, So A, Lam TK, Lam L, Lewis GF, Mari A, Giacca A.

Am J Physiol Endocrinol Metab. 2007 Feb;292(2):E549-60. Epub 2006 Sep 26.

8.

Pioglitazone reverses down-regulation of cardiac PPARgamma expression in Zucker diabetic fatty rats.

Pelzer T, Jazbutyte V, Arias-Loza PA, Segerer S, Lichtenwald M, Law MP, Schäfers M, Ertl G, Neyses L.

Biochem Biophys Res Commun. 2005 Apr 8;329(2):726-32.

PMID:
15737646
9.

Activation of PPARgamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats.

Golfman LS, Wilson CR, Sharma S, Burgmaier M, Young ME, Guthrie PH, Van Arsdall M, Adrogue JV, Brown KK, Taegtmeyer H.

Am J Physiol Endocrinol Metab. 2005 Aug;289(2):E328-36. Epub 2005 Mar 29.

10.

Defective fatty acid-mediated beta-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes.

Hirose H, Lee YH, Inman LR, Nagasawa Y, Johnson JH, Unger RH.

J Biol Chem. 1996 Mar 8;271(10):5633-7.

11.

L-3-11C-lactate as a PET tracer of myocardial lactate metabolism: a feasibility study.

Herrero P, Dence CS, Coggan AR, Kisrieva-Ware Z, Eisenbeis P, Gropler RJ.

J Nucl Med. 2007 Dec;48(12):2046-55.

12.
14.

Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats.

Wang P, Lloyd SG, Zeng H, Bonen A, Chatham JC.

Am J Physiol Heart Circ Physiol. 2005 May;288(5):H2102-10. Epub 2004 Dec 22.

15.

Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes.

Leonard BL, Watson RN, Loomes KM, Phillips AR, Cooper GJ.

Acta Diabetol. 2005 Dec;42(4):162-70.

PMID:
16382303
16.
17.
18.

Glucose transporter levels in tissues of spontaneously diabetic Zucker fa/fa rat (ZDF/drt) and viable yellow mouse (Avy/a).

Slieker LJ, Sundell KL, Heath WF, Osborne HE, Bue J, Manetta J, Sportsman JR.

Diabetes. 1992 Feb;41(2):187-93.

PMID:
1733808
19.

Down-regulation of orexin gene expression by severe obesity in the rats: studies in Zucker fatty and zucker diabetic fatty rats and effects of rosiglitazone.

Cai XJ, Lister CA, Buckingham RE, Pickavance L, Wilding J, Arch JR, Wilson S, Williams G.

Brain Res Mol Brain Res. 2000 Apr 14;77(1):131-7.

PMID:
10814839

Supplemental Content

Support Center